C. Dooms

C. Dooms, J. Vansteenkiste, E. Verbeken, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Lung Aeration in COVID-19 Pneumonia by Ultrasonography and Computed Tomography

C. Dooms, D. Testelmans, E. Wauters, 2022, Journal of clinical medicine.

Central airway obstruction

C. Dooms, A. Rosell, 2017 .

The impact of endoscopic lung volume reduction on physical activity coaching in patients with severe emphysema

G. Verleden, C. Dooms, W. Janssens, 2022, ERJ Open Research.

Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.

C. Dooms, J. Vansteenkiste, P. D. De Leyn, 2009, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Value of [68Ga]Ga-somatostatin receptor PET/CT in the grading of pulmonary neuroendocrine (carcinoid) tumours and the detection of disseminated disease: single-centre pathology-based analysis and review of the literature

C. Dooms, K. Nackaerts, B. Weynand, 2022, EJNMMI Research.

Patterns of Locoregional Relapses in Patients with Contemporarily Staged Stage III‐N2 NSCLC Treated with Induction Chemotherapy and Resection: Implications for Postoperative Radiotherapy Target Volumes

C. Dooms, D. de Ruysscher, P. Bulens, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Chapter 8 – Positron Emission Tomography Imaging

C. Dooms, J. Vansteenkiste, C. Deroose, 2012 .

The role of PET scan in diagnosis, staging, and management of non-small cell lung cancer.

Johan Vansteenkiste, Christophe Dooms, C. Dooms, 2004, The oncologist.

RNA-sequencing in non-small cell lung cancer shows gene downregulation of therapeutic targets in tumor tissue compared to non-malignant lung tissue

C. Dooms, K. Nackaerts, D. Lambrechts, 2018, Radiation Oncology.

Epithelial Cell and Lung Cancer: Introduction

C. Dooms, P. Barnes, 2010, Respiration.

Is Esophageal Ultrasound-Guided Fine Needle Aspiration the Last Stop on the Road to Accurate Mediastinal Staging?

C. Dooms, J. Vansteenkiste, 2009, Respiration.

Esophageal ultrasound-controlled fine needle aspiration for staging of mediastinal lymph nodes in patients with resectable lung cancer: do we always see the reality?

C. Dooms, J. Vansteenkiste, P. D. De Leyn, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Should we abandon standard forceps biopsy to diagnose an endobronchial lesion?

C. Dooms, 2012, European Respiratory Journal.

INSIGHT 2: a Phase II study of tepotinib plus osimertinib in MET-amplified NSCLC and first-line osimertinib resistance.

C. Dooms, Yi-long Wu, J. Mazières, 2021, Future oncology.

Probe-based confocal laser endomicroscopy of the respiratory tract: a data consistency analysis.

G. Verleden, C. Dooms, M. Decramer, 2013, Respiratory medicine.

Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience.

C. Dooms, K. Nackaerts, J. Vansteenkiste, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Definition of synchronous oligo-metastatic non-small cell lung cancer - a consensus report.

C. Dooms, N. Girard, H. Gietema, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Remote System for Daily Symptom Monitoring During Systemic Anticancer Treatment

C. Dooms, H. Wildiers, A. Coolbrandt, 2021, Cancer nursing.

1,25-Dihydroxyvitamin D Modulates Antibacterial and Inflammatory Response in Human Cigarette Smoke-Exposed Macrophages

C. Dooms, W. Janssens, C. Mathieu, 2016, PloS one.

The impact of trafﬁc air pollution on bronchiolitis obliterans syndrome and mortality after lung transplantation

G. Verleden, C. Dooms, C. Faes, 2022 .

C. Dooms, K. Nackaerts, K. Laere, 2022, EJNMMI Research.

Abstract CT169: Poziotinib administered twice daily improves safety and tolerability in patients with EGFR or HER2 exon 20 mutant NSCLC(ZENITH20-5)

C. Dooms, M. Socinski, J. Riess, 2021, Clinical Trials.

Front & Back Matter

Amsterdam, C. Dooms, S. Gasparini, 2016, Respiration.

Endoscopic advanced imaging of the respiratory tract: exploring probe-based confocal laser endomicroscopy in emphysema

G. Verleden, C. Dooms, J. Yserbyt, 2017, Thorax.

Front & Back Matter

Amsterdam, C. Dooms, V. Cottin, 2016, Respiration.

An Asymptomatic Patient with Severe Airway Obstruction

C. Dooms, M. Decramer, E. Verbeken, 2010, Respiration.

Cost–utility analysis of chemotherapy in symptomatic advanced nonsmall cell lung cancer

C. Dooms, J. Vansteenkiste, Y. Lievens, 2006, European Respiratory Journal.

The Feasibility of Tracheal Oxygen Supplementation during Flexible Bronchoscopy

C. Dooms, V. Ninane, M. Bruyneel, 2016, Respiration.

Prevalence and Clinical Outcomes for Patients With ALK Gene Rearrangement in Europe: Preliminary Results from the European Thoracic Oncology Platform Lungscape Project

C. Dooms, L. Bubendorf, K. O'Byrne, 2012 .

CARDIO-THORACIC SURGERY

C. Dooms, J. Vansteenkiste, T. Lerut, 2009 .

MA25.03 Defining Oligometastatic Non-Small Cell Lung Cancer (NSCLC): An Evolving Multidisciplinary Expert Opinion

C. Dooms, D. de Ruysscher, A. Dingemans, 2018, Journal of Thoracic Oncology.

Hemolytic anemia caused by alectinib, an Anaplastic Lymphoma Kinase (ALK) inhibitor: a case report

C. Dooms, K. Nackaerts, E. Wauters, 2022, Current Problems in Cancer: Case Reports.

Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial

C. Dooms, P. Lambin, L. Dubois, 2020, BMC Cancer.

Lung cancer staging: a concise update

Ramón Rami-Porta, Christophe Dooms, C. Dooms, 2018, European Respiratory Journal.

Pulmonary alveolar microlithiasis and probe-based confocal laser endomicroscopy.

C. Dooms, V. Ninane, T. Alamé, 2013, Journal of bronchology & interventional pulmonology.

Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trial.

C. Dooms, A. Nicholson, K. Rabe, 2010, JAMA.

C. Dooms, P. Lambin, L. Dubois, 2020, BMC Cancer.

Hematopoietic Growth Factors in Lung Cancer

C. Dooms, J. Vansteenkiste, 2004 .

CYFRA 21.1 in bronchoalveolar lavage of idiopathic pulmonary fibrosis patients

G. Verleden, C. Dooms, S. Verleden, 2015, Experimental lung research.

Programmed death-ligand 1 expression influenced by tissue sample size. Scoring based on tissue microarrays’ and cross-validation with resections, in patients with, stage I–III, non-small cell lung carcinoma of the European Thoracic Oncology Platform Lungscape cohort

C. Dooms, K. Nackaerts, A. Warth, 2019, Modern Pathology.

Single-cell transcriptomics identifies pathogenic T-helper 17.1 cells and pro-inflammatory monocytes in immune checkpoint inhibitor-related pneumonitis

C. Dooms, K. Nackaerts, D. Lambrechts, 2022, Journal for ImmunoTherapy of Cancer.

Validation of a locked nucleic acid based wild-type blocking PCR for the detection of EGFR exon 18/19 mutations

C. Dooms, J. Vansteenkiste, P. Vandenberghe, 2015, Diagnostic Pathology.

Defining oligometastatic non-small cell lung cancer: A simulated multidisciplinary expert opinion.

C. Dooms, D. de Ruysscher, S. Novello, 2019, European journal of cancer.

Health Outcomes for Definite Concurrent Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer: A Prospective Study

C. Dooms, K. Tournoy, P. Vercauter, 2018, Respiration.

Combined modality treatment for malignant pleural mesothelioma: a single-centre long-term survival analysis using extrapleural pneumonectomy.

C. Dooms, K. Nackaerts, J. Vansteenkiste, 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Malignant pleural disease: diagnosis by using diffusion-weighted and dynamic contrast-enhanced MR imaging--initial experience.

C. Dooms, K. Nackaerts, S. Dymarkowski, 2012, Radiology.

Malignant pleural mesothelioma: visual assessment by using pleural pointillism at diffusion-weighted MR imaging.

C. Dooms, K. Nackaerts, S. Dymarkowski, 2015, Radiology.

Suitability of Small Bronchoscopic Tumour Specimens for Lung Cancer Genotyping

C. Dooms, K. Nackaerts, V. Ninane, 2014, Respiration.

Mechanical ventilation affects respiratory microbiome of COVID-19 patients and its interactions with the host

J. Raes, C. Dooms, D. Lambrechts, 2020, medRxiv.

Bronchial valve treatment for pulmonary air leak after anatomical lung resection for cancer

C. Dooms, V. Ninane, H. Decaluwé, 2013, European Respiratory Journal.

Endobronchial Valves for Persistent Postoperative Pulmonary Air Leak: Accurate Monitoring and Functional Implications

C. Dooms, V. Ninane, H. Decaluwé, 2012, Respiration.

Large Bronchopleural Fistula After Surgical Resection: Secret to Success.

C. Dooms, W. Budts, Isabelle Delanote, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Influence of cisplatin-use, age, performance status and duration of chemotherapy on symptom control in advanced non-small cell lung cancer: detailed symptom analysis of a randomised study comparing cisplatin-vindesine to gemcitabine.

C. Dooms, K. Nackaerts, J. Vansteenkiste, 2003, Lung cancer.

Individualized therapy in the adjuvant setting for non-small cell lung cancer (NSCLC)

C. Dooms, F. Shepherd, C. Mascaux, 2013, Current Respiratory Care Reports.

Systematic review of symptom control and quality of life in studies on chemotherapy for advanced non-small cell lung cancer: how CONSORTed are the data?

C. Dooms, J. Vansteenkiste, K. Pat, 2008, Lung cancer.

The effect of chemotherapy on symptom control and quality of life in patients with advanced non-small cell lung cancer

C. Dooms, J. Vansteenkiste, K. Pat, 2006, Expert review of anticancer therapy.

Treatment of patients with advanced non-small cell lung cancer

C. Dooms, J. Vansteenkiste, 2004 .

Prevalence and clinical outcomes for patients with ALK-positive resected stage I to III adenocarcinoma: results from the European Thoracic Oncology Platform Lungscape Project.

C. Dooms, A. Marchetti, L. Bubendorf, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preoperative mediastinal lymph node staging for non-small cell lung cancer: 2014 update of the 2007 ESTS guidelines.

C. Dooms, R. Rami-Porta, P. V. Van Schil, 2014, Translational lung cancer research.

Lung cancer at the intensive care unit: The era of targeted therapy.

C. Dooms, J. Vansteenkiste, V. Adam, 2015, Lung cancer.

2nd ESMO Consensus Conference on Lung Cancer : non-small-cell lung cancer first-line/second and further lines in advanced disease

C. Dooms, A. Marchetti, L. Bubendorf, 2014 .

Generalized or personalized treatment for stage IIIA-N2 non-small-cell lung cancer?

C. Dooms, J. Vansteenkiste, V. Van Damme, 2010, Expert opinion on pharmacotherapy.

A Randomized Clinical Trial of Flex 19G Needles versus 22G Needles for Endobronchial Ultrasonography in Suspected Lung Cancer

C. Dooms, K. Nackaerts, B. Weynand, 2018, Respiration.

Performance of standard procedures in detection of EGFR mutations in daily practice in advanced NSCLC patients selected according to the ESMO guideline: a large Caucasian cohort study

C. Dooms, K. Nackaerts, T. Roskams, 2014, Translational Respiratory Medicine.

Implementing capnography to help improve patient safety during procedural sedation: quality improvement in a high-volume gastroenterology department

C. Dooms, G. Van Assche, R. Bisschops, 2021, European journal of gastroenterology & hepatology.

Endobronchial ultrasound in the management of nonsmall cell lung cancer

C. Dooms, V. Ninane, J. Yserbyt, 2013, European Respiratory Review.

Productive Cough and Bilateral Ptosis

C. Dooms, Ninane, J. Yserbyt, 2018 .

Acute lung allograft rejection: diagnostic role of probe-based confocal laser endomicroscopy of the respiratory tract.

Marc Decramer, Christophe Dooms, G. Verleden, 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Current Practice of Airway Stenting in the Adult Population in Europe: A Survey of the European Association of Bronchology and Interventional Pulmonology (EABIP)

C. Dooms, F. Herth, R. Eberhardt, 2017, Respiration; international review of thoracic diseases.

RNA-sequencing in non-small cell lung cancer shows gene downregulation of therapeutic targets in tumor tissue compared to non-malignant lung tissue

C. Dooms, K. Nackaerts, D. Lambrechts, 2018, Radiation oncology.

Learning Curve in Tracheal Allotransplantation

G. Verleden, C. Dooms, H. Decaluwé, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Tracheal autotransplantation: Guidelines for optimal functional outcome

C. Dooms, R. Hermans, J. Meulemans, 2011, The Laryngoscope.

Positron-emission tomography in prognostic and therapeutic assessment of lung cancer: systematic review.

C. Dooms, J. Mortensen, J. Vansteenkiste, 2004, The Lancet. Oncology.

Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer.

C. Dooms, R. Rami-Porta, P. V. Van Schil, 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

LBA52 Tepotinib + osimertinib for EGFRm NSCLC with MET amplification (METamp) after progression on first-line (1L) osimertinib: Initial results from the INSIGHT 2 study

C. Dooms, F. de Marinis, J. Mazières, 2022, Annals of Oncology.

Screening and early detection of lung cancer.

C. Dooms, K. Nackaerts, J. Vansteenkiste, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Patient-reported outcomes (PRO) from the phase 2 CodeBreaK 100 trial evaluating sotorasib in KRAS p.G12C mutated non-small cell lung cancer (NSCLC).

C. Dooms, G. Shapiro, F. Barlesi, 2021 .

2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up.

S Senan, C. Dooms, A. Marchetti, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Consensus Conference on Lung Cancer : early-stage non-small-cell lung cancer consensus on diagnosis , treatment and follow-up

C. Dooms, G. Veronesi, R. Stahel, 2014 .

Outcome after PORT in ypN2 or R1/R2 versus no PORT in ypN0 Stage III‐N2 NSCLC after Induction Chemotherapy and Resection

C. Dooms, D. de Ruysscher, P. Bulens, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The impact of traffic air pollution on bronchiolitis obliterans syndrome and mortality after lung transplantation

G. Verleden, C. Dooms, C. Faes, 2011, Thorax.

Diagnostic procedures for non-small-cell lung cancer (NSCLC): recommendations of the European Expert Group

C. Dooms, M. Dietel, L. Bubendorf, 2015, Thorax.

Evaluation of NGS and RT‐PCR Methods for ALK Rearrangement in European NSCLC Patients: Results from the European Thoracic Oncology Platform Lungscape Project

C. Dooms, K. Nackaerts, A. Warth, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Pan-cancer detection and typing by mining patterns in large genome-wide cell-free DNA sequencing datasets

C. Dooms, D. Timmerman, P. Neven, 2022, medRxiv.

Principles of Rehabilitation and Reactivation

C. Dooms, W. Janssens, T. Troosters, 2015, Respiration.

WHY A CHEST PHYSICIAN SHOULD BE INTERESTED IN ABDOMINAL PAIN

C. Dooms, D. Van raemdonck, S. Bostoen, 2011, Acta clinica Belgica.

Is central lung tumour location really predictive for occult mediastinal nodal disease in (suspected) non-small-cell lung cancer staged cN0 on 18F-fluorodeoxyglucose positron emission tomography–computed tomography?

C. Dooms, K. Nackaerts, D. de Ruysscher, 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Integrated PET/CT and Linear Endosonography (EBUS and EUS)

C. Dooms, C. Deroose, 2015 .

Bronchial carcinoma after lung transplantation: a single-center experience.

G. Verleden, C. Dooms, L. Dupont, 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Computed Tomography Characteristics Predictive for Radial EBUS-Miniprobe-Guided Diagnosis of Pulmonary Lesions

C. Dooms, V. Ninane, D. Testelmans, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Metabolic phenotyping of human blood plasma: a powerful tool to discriminate between cancer types?

C. Dooms, P. Adriaensens, J. Vansteenkiste, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Corrigendum to “Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: A meta-analysis” [Radiother Oncol 110 (2014) 3–8]

C. Dooms, K. Haustermans, D. Ruysscher, 2014 .

Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: a meta-analysis.

C. Dooms, K. Haustermans, D. de Ruysscher, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Maintenance Therapy for Advanced Non–Small-Cell Lung Cancer: A Pilot Study on Patients’ Perceptions

C. Dooms, K. Nackaerts, J. Vansteenkiste, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Invasive mediastinal staging by endosonography or video-assisted mediastinoscopy in PET-CT clinical N1 non-small cell lung cancer

C. Dooms, H. Decaluwé, 2020, Mediastinum.

Systematic and combined endosonographic staging of lung cancer (SCORE study)

C. Dooms, J. Annema, K. Tournoy, 2019, European Respiratory Journal.

Adding an invasive procedure will not necessarily change treatment or outcome of NSCLC patients with preoperative clinical N1 disease

C. Dooms, R. Rami-Porta, H. Decaluwé, 2018, European Respiratory Journal.

Mediastinal staging by videomediastinoscopy in clinical N1 non-small cell lung cancer: a prospective multicentre study

C. Dooms, R. Rami-Porta, W. Klepetko, 2017, European Respiratory Journal.

Endosonography for mediastinal nodal staging of clinical N1 non-small cell lung cancer: a prospective multicenter study.

C. Dooms, H. Decaluwé, K. Tournoy, 2015, Chest.

Anastomotic airway complications after lung transplantation: risk factors, treatment modalities and outcome-a single-centre experience.

G. Verleden, C. Dooms, L. Dupont, 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Clinical effectiveness and cost-effectiveness of endobronchial and endoscopic ultrasound relative to surgical staging in potentially resectable lung cancer: results from the ASTER randomised controlled trial.

C. Dooms, L. Sharples, M. Buxton, 2012, Health technology assessment.

Multicentric evaluation of the impact of central tumour location when comparing rates of N1 upstaging in patients undergoing video-assisted and open surgery for clinical Stage I non-small-cell lung cancer†

C. Dooms, D. Gossot, T. Schmid, 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Five-Year Survival After Endosonography vs Mediastinoscopy for Mediastinal Nodal Staging of Lung Cancer.

C. Dooms, J. Annema, R. Rintoul, 2016, JAMA.

The maximum uptake of 18F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1α and GLUT-1 in non-small cell lung cancer

Sigrid Stroobants, Philippe Lambin, Cary Dehing-Oberije, 2007 .

Cost effectiveness of endosonography versus surgical staging in potentially resectable lung cancer: a health economics analysis of the ASTER trial from a European perspective

C. Dooms, L. Sharples, J. Annema, 2013, Thorax.

Clinical factors predictive of long-term survival in advanced non-small cell lung cancer.

C. Dooms, K. Nackaerts, J. Vansteenkiste, 2013, Lung cancer.

Direct EBUS‐guided transtracheal lymphosclerosis for plastic bronchitis after Fontan

C. Dooms, M. Gewillig, G. Maleux, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Emerging Applications of Positron Emission Tomography Imaging in the Management of Patients With Lung Cancer

C. Dooms, M. Socinski, F. Detterbeck, 2015 .

Positron emission tomography in nonsmall cell lung cancer

C. Dooms, J. Vansteenkiste, 2007, Current opinion in pulmonary medicine.

Seeking a home for a PET, part 3: Emerging applications of positron emission tomography imaging in the management of patients with lung cancer.

C. Dooms, M. Socinski, F. Detterbeck, 2004, Chest.

Real-time symptom management in the context of a remote symptom-monitoring system: prospective process evaluation and cross-sectional survey to explore clinical relevance

C. Dooms, H. Wildiers, A. Coolbrandt, 2021, Supportive Care in Cancer.

Detection of Lung Cancer through Metabolic Changes Measured in Blood Plasma

C. Dooms, P. Adriaensens, Z. Shkedy, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Positron emission tomography in nonsmall cell lung cancer

C. Dooms, J. Vansteenkiste, 2007, Current opinion in oncology.

Additional value of whole-body fluorodeoxyglucose positron emission tomography in the detection of distant metastases of non-small-cell lung cancer.

C. Dooms, P. Dupont, L. Mortelmans, 2003, Clinical lung cancer.

Abstract CT033: KontRASt-01: A phase Ib/II, dose-escalation study of JDQ443 in patients (pts) with advanced, KRAS G12C-mutated solid tumors

C. Dooms, Toshio Shimizu, R. Heist, 2022, Cancer Research.

LBA78 A microsimulation model to assess the impact of SARS-CoV-2 on cancer outcomes, healthcare organization and economic burden

C. Dooms, K. Nackaerts, D. Lambrechts, 2020, Annals of Oncology.

Abstract CT008: Long-term outcomes with sotorasib in pretreated KRASp.G12C-mutated NSCLC: 2-year analysis of CodeBreaK100

C. Dooms, J. Desai, R. Govindan, 2022, Cancer Research.

Endobronchial Ultrasonography in Bronchoscopic Occult Pulmonary Lesions

C. Dooms, H. Becker, J. Vansteenkiste, 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Placental growth factor contributes to bronchial neutrophilic inflammation and edema in allergic asthma.

C. Dooms, P. Carmeliet, P. Hellings, 2012, American journal of respiratory cell and molecular biology.

Treatment of unresectable stage III NSCLC: Real world cohort study and literature review.

C. Dooms, K. Nackaerts, J. Vansteenkiste, 2023, Cancer treatment and research communications.

Targeted RNA sequencing for upfront analysis of actionable driver alterations in non-small cell lung cancer.

C. Dooms, B. Weynand, J. Vansteenkiste, 2022, Lung cancer.

Association Between 18F-Fluoro-2-Deoxy-d-Glucose Uptake Values and Tumor Vitality: Prognostic Value of Positron Emission Tomography in Early-Stage Non-small Cell Lung Cancer

C. Dooms, D. de Ruysscher, J. Vansteenkiste, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Lung volume reduction in emphysema: a pragmatic prospective cohort study

G. Verleden, C. Dooms, W. Janssens, 2021, ERJ Open Research.

Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRAS G12C mutation: a randomised, open-label, phase 3 trial

C. Dooms, Melissa L. Johnson, S. Novello, 2023, The Lancet.

The maximum uptake of (18)F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1alpha and GLUT-1 in non-small cell lung cancer.

Philippe Lambin, Cary Dehing-Oberije, Dirk De Ruysscher, 2007, European journal of cancer.

Initial Evidence for the Efficacy of Naporafenib in Combination With Trametinib in NRAS-Mutant Melanoma: Results From the Expansion Arm of a Phase Ib, Open-Label Study

D. Schadendorf, C. Dooms, P. Ascierto, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-Term Outcomes and Molecular Correlates of Sotorasib Efficacy in Patients With Pretreated KRAS G12C-Mutated Non–Small-Cell Lung Cancer: 2-Year Analysis of CodeBreaK 100

C. Dooms, R. Govindan, S. Ramalingam, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Is there a different dose–effect relation between the primary tumor and involved lymph nodes in locally advanced non-small-cell lung cancer? A hypothesis-generating study

C. Dooms, D. de Ruysscher, S. Peeters, 2017, Acta oncologica.

The Role of Flexible Bronchoscopy in Swab-negative Patients During the SARS-CoV2 Pandemic.

G. Verleden, C. Dooms, D. Testelmans, 2020, Journal of bronchology & interventional pulmonology.

2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer.

C. Dooms, A. Marchetti, K. Syrigos, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[68Ga]Ga-DOTATATE-avid tumor volume, uptake and inflammation-based index correlate with survival in neuroendocrine tumor patients treated with [177Lu]Lu-DOTATATE PRRT.

C. Dooms, E. Van Cutsem, K. Goffin, 2022, American journal of nuclear medicine and molecular imaging.

Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer.

C. Dooms, A. Marchetti, L. Bubendorf, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Central tumour location should be considered when comparing N1 upstaging between thoracoscopic and open surgery for clinical stage I non-small-cell lung cancer.

C. Dooms, S. Peeters, S. Fieuws, 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Diagnostic bronchoscopy: state of the art

C. Dooms, V. Ninane, S. Gasparini, 2010, European Respiratory Review.

2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease.

P Baas, C. Dooms, A. Marchetti, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Intracranial and systemic efficacy of repotrectinib in advanced ROS1 fusion-positive (ROS1+) non-small cell lung cancer (NSCLC) and central nervous system metastases (CNS mets) in the phase 1/2 TRIDENT-1.

C. Dooms, A. Drilon, E. Felip, 2023, Journal of Clinical Oncology.

Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer.

C. Dooms, M. Tsuboi, H. Wakelee, 2023, The New England journal of medicine.

Staging of Lung Cancer.

C. Dooms, J. Vansteenkiste, S. Stroobants, 2006, PET clinics.

Characterisation of solitary pulmonary lesions combining visual perfusion and quantitative diffusion MR imaging

C. Dooms, K. Nackaerts, S. Dymarkowski, 2014, European Radiology.

Complete and systematic mediastinal nodal staging for lung cancer (SCORE study)

C. Dooms, J. Annema, K. Tournoy, 2017 .

Clinical management and relevance of an alert feature for real-time symptom management in a mobile tool for self-monitoring and self-management of symptoms during anticancer treatment

C. Dooms, H. Wildiers, A. Coolbrandt, 2020 .

Single-celltranscriptomicsidentifies pathogenic T-helper 17.1 cells and pro-inflammatorymonocytesinimmune checkpoint inhibitor-related pneumonitis

C. Dooms, K. Nackaerts, D. Lambrechts, 2022 .

The challenge of molecular testing for clinical trials in advanced non-small cell lung cancer patients: Analysis of a prospective database.

C. Dooms, K. Nackaerts, B. Weynand, 2016, Lung cancer.

Learning Curve in Tracheal Allotransplantation

G. Verleden, C. Dooms, H. Decaluwé, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Prevalence and clinical outcomes for patients with ALK-positive resected stage I to III adenocarcinoma: results from the European Thoracic Oncology Platform Lungscape Project.

C. Dooms, A. Marchetti, L. Bubendorf, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomized trial comparing endosonography followed by surgical staging versus surgical mediastinal staging alone in non-small cell lung cancer: The ASTER study.

C. Dooms, A. Nicholson, K. Rabe, 2010 .

Diagnostic procedures for non-small-cell lung cancer (NSCLC): recommendations of the European Expert Group

C. Dooms, M. Dietel, L. Bubendorf, 2015, Thorax.

Staging of Lung Cancer.

R. M. Peters, C. Dooms, J. Vansteenkiste, 2006, PET clinics.

Endobronchial ultrasound-guided transbronchial needle biopsy for M1 staging of extrathoracic malignancies.

C. Dooms, T. Malfait, K. Tournoy, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

The impact of traffic air pollution on bronchiolitis obliterans syndrome and mortality after lung transplantation

G. Verleden, C. Dooms, C. Faes, 2011, Thorax.

KontRASt-01 update: Safety and efficacy of JDQ443 in KRAS G12C-mutated solid tumors including non-small cell lung cancer (NSCLC).

C. Dooms, E. Felip, M. Schuler, 2023, Journal of Clinical Oncology.

Pulmonary alveolar microlithiasis and probe-based confocal laser endomicroscopy.

C. Dooms, V. Ninane, T. Alamé, 2013, Journal of bronchology & interventional pulmonology.